97 studies found for:    "tumor necrosis factor receptor-associated periodic syndrome" [DISEASE] OR NCT00094900 [ID-NUMBER] OR NCT00442182 [ID-NUMBER] OR NCT01242813 [ID-NUMBER]
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS)
Condition: TNF-receptor Associated Periodic Syndromes (TRAPS)
Intervention: Drug: ACZ885
2 Unknown  The Efficacy and Safety of ITF2357 in AIS
Conditions: Autoinflammatory Syndromes;   HIDS;   TRAPS;   Schnitzler's Syndrome
Intervention: Drug: ITF2357
3 Completed
Has Results
Interleukin-1 Trap to Treat Autoinflammatory Diseases
Conditions: Inflammation;   Familial Mediterranean Fever;   Still's Disease, Adult-Onset
Intervention: Drug: IL-1 Trap
4 Recruiting Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Device: Trap Myelin Test
5 Recruiting Neutrophil Extracellular Trap Formation in Patients Undergoing Bone Marrow Transplant
Condition: Bone Marrow Transplant
Intervention:
6 Recruiting Neutrophil Extracellular Trap Formation in Newborn Infants at Risk for Necrotizing Enterocolitis
Conditions: Prematurity;   Necrotizing Enterocolitis
Intervention:
7 Recruiting Neutrophil Extracellular Traps Formation Post-hematopoietic Stem Cell Transplantation
Condition: Childhood Cancer
Intervention:
8 Completed The Effect of a Retrofit Particle Trap on the Vascular Effects of Diesel Exhaust Inhalation
Condition: Heart Disease
Intervention: Procedure: Forearm Venous Occlusion Plethysmography
9 Recruiting Neutrophil Extracellular Traps (NETs) Formation Following Chemotherapy and Their Role in Antitumor Activity
Conditions: Pediatric Solid Malignancies;   Pediatric Hematological Malignancies
Intervention:
10 Completed Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema)
Condition: Macular Edema
Intervention: Biological: VEGF Trap-Eye (BAY86-5321)
11 Completed
Has Results
Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD
Condition: Macular Degeneration
Intervention: Drug: VEGF Trap Eye
12 Active, not recruiting Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement
Condition: Macular Edema
Interventions: Biological: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321);   Procedure: Laser photocoagulation
13 Completed
Has Results
AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites
Condition: Ovarian Neoplasms
Intervention: Drug: Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)
14 Active, not recruiting Study of Intravitreal Administration of VEGF Trap-Eye (BAY86-5321) in Patients With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: VEGF Trap-Eye;   Procedure: Laser treatment
15 Completed Extension Study of the Use of Vascular Endothelial Growth Factor (VEGF) Trap-Eye in Neovascular Age-Related Macular Degeneration (AMD)
Condition: Neovascular Age-related Macular Degeneration
Intervention: Drug: VEGF Trap-Eye
16 Completed
Has Results
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
Condition: Retinal Vein Occlusion
Interventions: Biological: Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321);   Other: Sham treatment
17 Completed
Has Results
Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer
Conditions: Neoplasms;   Cancer of the Ovary
Intervention: Drug: Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)
18 Completed
Has Results
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
Condition: Macular Edema Secondary to Central Retinal Vein Occlusion
Interventions: Biological: VEGF Trap-Eye 2.0mg;   Drug: Sham
19 Recruiting Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)
Condition: Renal Insufficiency, Chronic
Interventions: Drug: Rilonacept;   Drug: Placebo
20 Unknown  The HIT-TRAP Trial
Condition: Heparin-Induced Thrombocytopenia
Intervention: Drug: Standard heparin (UFH) versus certoparin (LMWH)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years